Greenwich LifeSciences, Inc. (GLSI): auditor change — Greenwich LifeSciences dismisses RBSM, hires MaloneBailey as auditor effective July 19, 2025

Greenwich LifeSciences, Inc.

Audit committee approved dismissing RBSM LLP and engaging MaloneBailey LLP for fiscal 2025 audit.
RBSM's reports for 2024 and 2023 were unqualified; no disagreements on accounting or auditing matters.
Prior material weaknesses in internal control over financial reporting were discussed with RBSM and disclosed in earlier SEC filings.
RBSM provided a letter to the SEC, attached as Exhibit 16.1, agreeing with the Company's disclosures.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Greenwich LifeSciences, Inc. engaged MaloneBailey LLP as its auditor.

Action: engagement
Auditor: MaloneBailey LLP

Exact text from the filing

On July 19, 2025, the audit committee of the Board of Directors of Greenwich LifeSciences, Inc. (the "Company") approved the dismissal of RBSM LLP ("RBSM") as the Company's independent registered public accounting firm and approved the engagement of MaloneBailey LLP ("MaloneBailey") as the Company's independent registered public accounting firm

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Greenwich LifeSciences, Inc. dismissed RBSM LLP as its auditor.

Action: dismissal
Auditor: RBSM LLP
Successor: MaloneBailey LLP

Exact text from the filing

On July 19, 2025, the audit committee of the Board of Directors of Greenwich LifeSciences, Inc. (the "Company") approved the dismissal of RBSM LLP ("RBSM") as the Company's independent registered public accounting firm

View on SEC.gov

Browse all auditor changes →

Greenwich LifeSciences, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-020843

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.